CClinicalTrials.gg
CompletedNCT03868930STEP-HomeUpdated Oct 30, 2025Results posted

Multisite RCT of STEP-Home: A Transdiagnostic Skill-based Community Reintegration Workshop

An interventional study of STEP-Home and PCGT in Post-traumatic Stress Disorder, Traumatic Brain Injury and Substance Related Disorders, sponsored by VA Office of Research and Development. Completed at 2 sites in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-30.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
221
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

In this proposal, the investigators extend their previous SPiRE feasibility and preliminary effectiveness study to examine STEP-Home efficacy in a RCT design. This novel therapy will target the specific needs of a broad range of underserved post-9/11 Veterans. It is designed to foster reintegration by facilitating meaningful improvement in the functional skills most central to community participation: emotional regulation (ER), problem solving (PS), and attention functioning (AT). The skills trained in the STEP-Home workshop are novel in their collective use and have not been systematically applied to a Veteran population prior to the investigators' SPiRE study. STEP-Home will equip Veterans with skills to improve daily function, reduce anger and irritability, and assist reintegration to civilian life through return to work, family, and community, while simultaneously providing psychoeducation to promote future engagement in VA care.

The innovative nature of the STEP-Home intervention is founded in the fact that it is: (a) an adaptation of an established and efficacious intervention, now applied to post-9/11 Veterans; (b) nonstigmatizing (not "therapy" but a "skills workshop" to boost acceptance, adherence and retention); (c) transdiagnostic (open to all post-9/11 Veterans with self-reported reintegration difficulties; Veterans often have multiple mental health diagnoses, but it is not required for enrollment); (d) integrative (focus on the whole person rather than specific and often stigmatizing mental and physical health conditions); (e) comprised of Veteran-specific content to teach participants cognitive behavioral skills needed for successful reintegration (which led to greater acceptability in feasibility study); (f) targets anger and irritability, particularly during interactions with civilians; (g) emphasizes psychoeducation (including other available treatment options for common mental health conditions); and (h) challenges beliefs/barriers to mental health care to increase openness to future treatment and greater mental health treatment utilization. Many Veterans who participated in the development phases of this workshop have gone on to trauma or other focused therapies, or taken on vocational (work/school/volunteer) roles after STEP-Home.

The investigators have demonstrated that the STEP-Home workshop is feasible and results in pre-post change in core skill acquisition that the investigators demonstrated to be directly associated with post-workshop improvement in reintegration status in their SPiRE study. Given the many comorbidities of this cohort, the innovative treatment addresses multiple aspects of mental health, cognitive, and emotional function simultaneously and bolsters reintegration in a short-term group to maximize cost-effectiveness while maintaining quality of care.

Read the detailed description

Post-9/11 Veterans who served in OEF/OIF face many challenges as they re-enter civilian life after structured military careers. Yet, underutilization and resistance to mental health treatment remains a significant problem. Recent investigations of community reintegration problems among returning Veterans found that half of combat Veterans who use Veterans Administration (VA) services reported difficulty in readjusting to civilian life, including difficulty in social functioning, productivity in work and school settings, community involvement, and self-care domains. High rates of marital, family, and cohabitation discord were reported, with 75% reporting a family conflict in the last week. At least one-third reported divorce, dangerous driving and risky behaviors, increased substance use, and impulsivity and anger control problems since deployment. Almost all Veterans expressed interest in receiving services to help readjust to civilian life, and receiving reintegration services at a VA facility was reported as the preferred way to receive help. Mental health and anger problems are often cited as driving Veterans' difficulties readjusting to civilian life. Anger is becoming more widely recognized for its involvement in the psychological adjustment problems of post-9/11 Veterans. Research has shown that anger directly influences treatment outcome. In fact, history of untreated PTSD and aggression have been demonstrated to be pervasive among post-9/11 Veterans who die by suicide in the months before death. Veterans with probable PTSD report more reintegration and anger problems, and greater interest in services than Veterans without. Reintegration and anger problems continue for years post-combat and may not resolve without intervention.

Research on TBI in post-9/11 Veterans underscores the need for programs that utilize an interdisciplinary approach to reintegration. Programs designed to address challenges of Veterans as they reintegrate in vocational environments, particularly integrative approaches, are greatly needed. The STEP-Home intervention provides such a program. STEP-Home includes focused cognitive and emotional regulation skills training and is informed by the most recent research with returning Veterans and available programs focused on reintegration in VA and military settings (e.g., Battlemind training).

Phase 1: Years 1 and 2 The investigators will initiate the study at the Boston VAMC and develop Standard Operating Procedures for the addition of site 2 in Phase 2.

Phase 2: Years 3 and 4 The investigators will initiate the study at the second site, the Houston VAMC, in Year 3. The investigators will apply in Year 2 for IRB approval to initiate site 2.

Hypotheses \& Aims

Primary Aim 1. Examine treatment effects of STEP-Home on primary outcomes relative to Present Centered Group Therapy (PCGT):

Hypothesis 1A. Participants randomized into the STEP-Home intervention will show improvement on reintegration, readjustment, and anger post-intervention (expressed by lower scores; less difficulty).

Military to Civilian Questionnaire (M2CQ), Post-Deployment Readjustment Inventory (PDRI), and State-Trait Anger Expression Inventory (STAXI-2) scores post-intervention (T4) \< baseline (T1)

Hypothesis 1B. Participants randomized into STEP-Home will show greater improvement in primary outcomes as compared to PCGT.

Change scores baseline (T1) to post-intervention (T4) STEP-Home > PCGT change scores Post-intervention (T4) primary outcome scores STEP-Home \< PCGT primary outcome scores (T4)

Primary Aim 2. Examine maintenance of treatment effects on primary outcomes:

Hypothesis 2: Treatment effects will be maintained at follow up in both groups. Differential treatment effect of STEP-Home over PCGT post-intervention (T4) will be maintained at follow up (T5).

Exploratory Aim 1. Explore treatment effects of STEP-Home on measures of mental health, functional and vocational status and cognitive secondary outcomes targeted indirectly in the workshop.

Exploratory Hypothesis 1. Acquisition of core skills (problem solving, emotional regulation, attention training) will mediate the effect of treatment on primary outcomes post-intervention and at follow up.

The successful completion of the aims proposed has the potential to significantly improve skills to foster civilian reintegration in post-9/11Veterans. Furthermore, the STEP-Home SPiRE feasibility study demonstrated that the workshop also serves as a gateway for Veterans who are hesitant to participate in traditional mental health treatments to promote openness and engagement in additional, critically needed, VA services. Given the high rate of treatment resistance in this cohort, developing acceptable interventions that promote treatment engagement and retention, and open the door to future VA care, is necessary to improve functional status and to reduce long-term healthcare costs of untreated mental health illnesses.

02

Conditions studied

  • Post-traumatic Stress Disorder
  • Traumatic Brain Injury
  • Substance Related Disorders
  • Depression
  • Anxiety Disorders
  • Suicide
  • Pain

Keywords

  • Mental health
  • Veterans health
03

In context

Stress Disorders, Post-Traumatic

2,239 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 554 are open to participants now.

This study's enrollment of 221 is above the median of 70 across 1,858 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Post-9/11 Veterans who report some reintegration, readjustment, or anger difficulty

    • i.e., Veterans who report "some difficulty" (Likert rating) on at least one of the primary measures: M2CQ; PDRI; STAXI-2
  • 18-75 years old (to avoid outcomes being affected by aging)
  • English-speaking (sessions will be conducted in English)
  • Agreeing to participate

    • i.e., completion of ICF/HIPAA

Exclusion criteria

Exclusion Criteria:

  • schizophreniform disorder/active psychosis
  • bipolar disorder
  • active suicidality/homicidality requiring crisis intervention
  • other severe psychiatric disorders prohibiting appropriate group participation
  • neurological diagnosis prohibiting appropriate group participation (excluding TBI)
  • current substance dependence
  • current participation in any other form of active behavioral therapy at the time of enrollment

    • e.g., Cognitive Processing Therapy, cognitive rehabilitation for mTBI, or other psychotherapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
221 participants (actual)

Study arms

  • Experimental
    STEP-Home

    The STEP-Home Arm involves a skills-based intervention focused on Emotional Regulation, Problem Solving, and Attention Training strategies.

    Behavioral: STEP-Home

  • Active comparator
    PCGT

    The Present Center Group Therapy (PCGT) Arm involves a nonspecific, supportive intervention, focused on identifying and discussing current life stressors.

    Behavioral: PCGT

Interventions

  • BehavioralSTEP-Home

    This group will meet for 2 hours a week for 12 weeks. The core skills of Emotional Regulation (ER) (45-minutes) and Problem Solving (PS) (45-minutes) are introduced and then integrated throughout all Veteran-specific content modules for practice and repetition for 12 weeks. Attention Training (AT) augments PS and ER core skills and is interspersed throughout group and individual sessions.

  • BehavioralPCGT

    The PCGT group will also meet for 2 hours a week for 12 weeks. It is a nonspecific and supportive intervention to control for the nonspecific benefits of the group experience (e.g., therapist contact, instillation of hope, expectation of improvement). It will focus on identifying and discussing current life stressors that contribute to reintegration difficulties, psychoeducation, and promotion of wellness and physical health.

06

What researchers measure

Primary outcomes

  1. Military to Civilian Questionnaire

    A 16-item measure of post-deployment community reintegration in post-9/11 Veterans. Higher scores indicate greater reintegration and functional difficulties. Min: 0, Max: 64

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  2. Post-deployment Readjustment Inventory (Change)

    A 36-item measure of readjustment in post-9/11 Veterans with six subscales (career challenges, social difficulties, intimate relationship problems, health concerns, concerns about deployment, and PTSD symptoms). Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Total score is calculated by adding the value of all items in all subscales. Career: Min: 5, Max: 25 Health: Min: 5, Max: 25 Intimate Relationship: Min: 5, Max: 25 Social readjustment: Min: 7, Max: 35 Concerns about deployment: Min: 6, Max: 30 PTSD symptoms: Min: 8, Max: 40 TOTAL score: Min: 36, Max: 180

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  3. State-Trait Anger Expression Inventory (STAXI-2) (Change)

    A 57-item widely used measure to assess state anger, trait anger, and anger expression with three subscales (state anger, trait anger, and anger expression). Min and max scores for the subscales, and the total score, are below. For all, lower scores are better. How I Feel Right Now (State Anger): Min: 10, Max: 40, Calculated by summing 15 items in scale How I Generally Feel (Trait Anger): Min: 10, Max: 40, Calculated by summing 15 items in scale When Angry or Furious (Anger expression index): Min: 24, Max: 96, Calculated by summing anger control scores for each item (12 items) and subtracting that from sum of anger expression scores for each item (12 items)

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

Secondary outcomes

  1. Attention-Related Cognitive Errors Scale (ARCES) (Change)

    Measure of everyday performance failures arising from brief failures of sustained attention. Min: 12, Max: 60 (lower scores are better)

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  2. Problem Solving Inventory (PSI) (Change)

    Measure of problem solving confidence, approach-avoidance style, and personal control. Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Total score calculated by adding the scores of all items. Problem-Solving Confidence: Min: 11, Max: 66 Approach-Avoidance Style: Min: 16, Max: 96 Personal Control: Min: 5, Max: 30 TOTAL score: Min: 32, Max: 192

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  3. Difficulties in Emotion Regulation Scale (DERS) (Change)

    Measure to assess multiple aspects of emotion dysregulation. Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Nonacceptance of emotional responses: Min: 6, Max: 30 Difficulty engaging in goal-directed behavior: Min: 6, Max: 25 Impulse control difficulties: Min: 6, Max: 30 Lack of emotional awareness: Min: 6, Max: 30 Limited access to emotion regulation strategies: Min: 8, Max: 40 Lack of emotional clarity: Min: 5, Max: 25 TOTAL score: Min: 36, Max: 180, Total score calculated by adding the scores of all items (reverse scoring awareness items).

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  4. PTSD Checklist for DSM-5 (PCL-5) (Change)

    A 20-item measure of PTSD updated for DSM-5. Min: 0, Max: 80 (lower scores are better)

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  5. Depression Anxiety and Stress Scale (DASS-21) (Change)

    A 21-item measure of current depression, anxiety, and stress. Each subscale Min: 7, Max: 28 (lower scores are better)

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  6. Neurobehavioral Symptoms Inventory (NSI) (Change)

    A 22-item measure of current post-concussive symptoms. Total score Min: 0, Max: 88 (lower scores are better), calculated by adding the scores of all of the subscales. Vestibular Min: 0, Max: 12 (3 items) Somatosensory Min: 0, Max: 20 (5 items) Affective Min: 0, Max: 24 (6 items) Cognitive Min: 0, Max: 32 (8 items)

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  7. World Health Organization Disability Assessment Schedule-2.0 (WHODAS-2.0) (Change)

    Measures functional states in six domains (understanding and communicating, getting around, self care, getting along with people, life activities (work/school), and participation in society). Possible raw min and max scores are below. For all subscales and total score, data is presented as a computed score in a range from 0-100. This is calculated by taking the raw score for each subscale and total score, dividing it by number of possible points for the relevant questions, and multiplying it by 100. Lower scores are better. Understanding and Communicating: Min: 0, Max: 24 Getting Around: Min: 0, Max: 20 Self Care: Min: 0, Max: 16 Getting Along with People: Min: 0, Max: 20 Life Activities: Min: 0, Max: 16 Work-School: Min: 0, Max: 16 Participation: Min: 0, Max: 32 Total Aggregate: Min: 0, Max: 144

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  8. Satisfaction With Life Scale (SWLS) (Change)

    A 5-item measure of satisfaction with life. Min: 5, Max: 35 (higher scores are better)

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  9. Number of Participants Differing in Activity Engagement Over Time (Change)

    Assesses engagement in school, work, and life activities. Participants self reported engagement in each category at each time point. Categories are not mutually exclusive, but rather indicate how many participants endorsed participating in each category at each time point. A scale is not used in this measure.

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  10. Barriers to Employment Success Inventory (BESI) (Change)

    A measure of obstacles to employment in five areas (Personal/Financial, Emotional/Physical, Career Decision-Making and Planning, Job-Seeking Knowledge, and Training/Education). Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Only total score analyzed, subscales not reported. Personal and Financial: Min: 10, Max: 40 Emotional and Physical: Min: 10, Max: 40 Career Decision-Making and Planning: Min: 10, Max: 40 Job-Seeking Knowledge: Min: 10, Max: 40 Training and Education: Min: 10, Max: 40 TOTAL score: Min: 50, Max: 200

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  11. Number of Participants Differing in Average Number of Hours Worked (Change)

    Change in average number of hours worked per month over time. Participants self-reported average number of hours worked in the month before STEP-Home (baseline), in each month of the intervention/PCGT (measured at post-treatment), and post-treatment monitoring (follow-up). A scale is not used in this measure. Each row indicates the number of participants that worked the indicated number of hours at each time point. Rows are mutually exclusive.

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

  12. Frontal Systems Behavior Scale (FrSBe) (Change)

    Measures apathy, disinhibition, and executive dysfunction. Min and max possible scores for subscales and total score are below. For all, lower scores are better. Total score calculated by adding the scores of all items. Subscale scores calculated by adding the scores of the items in each subscale. Apathy Min: 14, Max: 70 Disinhibition Min: 15, Max: 75 Executive Dysfunction Min: 17, Max: 85 Total Score Min: 46, Max: 230

    Time frame: Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)

07

Results

Posted May 30, 2025
Limitations and caveats
The study sample is predominantly male and white, so results should not be generalized to other populations. Treatment outcomes were based on participant self-report. Low follow-up assessment rates were observed due to challenges retaining randomized participants who did not initiate treatment or dropped out of treatment over time, as well as lack of completion of assessments by treatment completers (although completion rates are within expectation for the post-9/11 population of Veterans).

Participant flow

Participants were recruited from VA clinical services, community partners (e.g., schools, Vet Centers, Veteran organizations), advertisements on social media (e.g., Facebook, Instagram), and the Veterans Affairs/Department of Defense Identity Repository.

Intervention & Post-Treatment Assessment
Participant flow — Intervention & Post-Treatment Assessment
MilestoneSTEP-HomePCGT
Started10095
Completed5357
Not completed4738
Withdrew: Lost to follow-up31
Withdrew: Physician decision14
Withdrew: Did not start treatment1816
Withdrew: Withdrawal by subject2517
Follow-Up Assessment
Participant flow — Follow-Up Assessment
MilestoneSTEP-HomePCGT
Started5357
Completed4445
Not completed912
Withdrew: Lost to follow-up912

Outcome measures

PrimaryMilitary to Civilian Questionnaire

A 16-item measure of post-deployment community reintegration in post-9/11 Veterans. Higher scores indicate greater reintegration and functional difficulties. Min: 0, Max: 64

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Military to Civilian Questionnaire
score on a scaleSTEP-HomePCGT
Baseline33.8 ± 13.234.7 ± 11.5
Post-Intervention25.5 ± 15.327.1 ± 11.2
Follow-Up24.4 ± 15.527.7 ± 11
Statistical analysis
  • STEP-Home · t-test, 2 sided · p = <.0001 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Post-Treatment (T2).)
  • STEP-Home · t-test, 2 sided · p = <.0001 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Follow-Up (T3).)
  • PCGT · t-test, 2 sided · p = <.0001 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Post-Treatment (T2).)
  • PCGT · t-test, 2 sided · p = <.0001 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Follow-Up (T3).)
PrimaryPost-deployment Readjustment Inventory (Change)

A 36-item measure of readjustment in post-9/11 Veterans with six subscales (career challenges, social difficulties, intimate relationship problems, health concerns, concerns about deployment, and PTSD symptoms). Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Total score is calculated by adding the value of all items in all subscales. Career: Min: 5, Max: 25 Health: Min: 5, Max: 25 Intimate Relationship: Min: 5, Max: 25 Social readjustment: Min: 7, Max: 35 Concerns about deployment: Min: 6, Max: 30 PTSD symptoms: Min: 8, Max: 40 TOTAL score: Min: 36, Max: 180

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Post-deployment Readjustment Inventory (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score117.1 ± 32.6121.0 ± 26.9
Post-Treatment Total Score107.8 ± 35.8116.2 ± 27.4
Follow-Up Total Score100.0 ± 37.9111.1 ± 27.5
Baseline Career Challenges15.5 ± 5.716.6 ± 4.5
Post-Treatment Career Challenges13.9 ± 5.215.5 ± 4.7
Follow-Up Career Challenges12.8 ± 5.814.8 ± 4.4
Baseline Health Concerns17.0 ± 5.718.0 ± 4.7
Post-Treatment Health Concerns15.7 ± 5.617.3 ± 4.9
Follow-Up Health Concerns14.4 ± 5.717.4 ± 5.0
Baseline Intimate Relationship Problems15.3 ± 5.616.0 ± 5.1
Post-Treatment Intimate Relationship Problems14.2 ± 5.614.8 ± 4.6
Follow-Up Intimate Relationship Problems13.3 ± 5.613.8 ± 4.5
Baseline Social Readjustment23.5 ± 7.324.5 ± 5.9
Post-Treatment Social Readjustment22.0 ± 7.523.8 ± 5.9
Follow-Up Social Readjustment20.8 ± 8.121.8 ± 6.0
Baseline Concerns About Deployment16.8 ± 6.217.5 ± 5.8
Post-Treatment Concerns About Deployment15.8 ± 6.416.6 ± 5.3
Follow-Up Concerns About Deployment14.5 ± 6.215.6 ± 5.5
Baseline PTSD Symptoms28.3 ± 8.330.0 ± 6.6
Post-Treatment PTSD Symptoms26.2 ± 9.028.1 ± 6.5
Follow-Up PTSD Symptoms24.3 ± 9.427.7 ± 6.8
Statistical analysis
  • STEP-Home · t-test, 2 sided · p = 0.0044 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Post-Treatment (T2).)
  • STEP-Home · t-test, 2 sided · p = <.0001 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Follow-Up (T3).)
  • PCGT · t-test, 2 sided · p = 0.0162 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Post-Treatment (T2).)
  • PCGT · t-test, 2 sided · p = 0.0009 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Follow-Up (T3).)
PrimaryState-Trait Anger Expression Inventory (STAXI-2) (Change)

A 57-item widely used measure to assess state anger, trait anger, and anger expression with three subscales (state anger, trait anger, and anger expression). Min and max scores for the subscales, and the total score, are below. For all, lower scores are better. How I Feel Right Now (State Anger): Min: 10, Max: 40, Calculated by summing 15 items in scale How I Generally Feel (Trait Anger): Min: 10, Max: 40, Calculated by summing 15 items in scale When Angry or Furious (Anger expression index): Min: 24, Max: 96, Calculated by summing anger control scores for each item (12 items) and subtracting that from sum of anger expression scores for each item (12 items)

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
State-Trait Anger Expression Inventory (STAXI-2) (Change)
score on a scaleSTEP-HomePCGT
Baseline State Anger25.8 ± 11.226.2 ± 9.2
Baseline Trait Anger21.9 ± 6.721.6 ± 6.2
Baseline Anger Index43.1 ± 14.442.0 ± 12.9
Post-Treatment State Anger22.8 ± 9.021.4 ± 7.3
Post-Treatment Trait Anger19.9 ± 7.120.6 ± 7.0
Post-Treatment Anger Index40.2 ± 13.041.9 ± 14.7
Follow-Up State Anger21.7 ± 10.021.9 ± 7.3
Follow-Up Trait Anger19.3 ± 6.118.5 ± 6.7
Follow-Up Anger Index37.7 ± 12.939.2 ± 14.5
Statistical analysis
  • STEP-Home · t-test, 2 sided · p = 0.0140 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Post-Treatment (T2) Trait Anger.)
  • STEP-Home · t-test, 2 sided · p = 0.1548 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Post-Treatment (T2) State Anger.)
  • STEP-Home · t-test, 2 sided · p = 0.0302 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Post-Treatment (T2) Anger Expression Index.)
  • PCGT · t-test, 2 sided · p = 0.0158 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Post-Treatment (T2) Trait Anger.)
  • PCGT · t-test, 2 sided · p = 0.0034 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Post-Treatment (T2) State Anger.)
  • PCGT · t-test, 2 sided · p = 0.8776 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Post-Treatment (T2) Anger Expression Index.)
  • STEP-Home · t-test, 2 sided · p = 0.0002 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Follow-Up (T3) Trait Anger.)
  • STEP-Home · t-test, 2 sided · p = 0.0198 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Follow-Up (T3) State Anger.)
  • STEP-Home · t-test, 2 sided · p = 0.0013 (P-value indicates significance of T-test (α=0.05) for the STEP-Home group from Baseline (T1) to Follow-Up (T3) Anger Expression Index.)
  • PCGT · t-test, 2 sided · p = <.0001 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy Group from Baseline (T1) to Follow-Up (T3) Trait Anger.)
  • PCGT · t-test, 2 sided · p = .0345 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Follow-Up (T3) State Anger.)
  • PCGT · t-test, 2 sided · p = 0.5918 (P-value indicates significance of T-test (α=0.05) for the Present Centered Group Therapy group from Baseline (T1) to Follow-Up (T3) Anger Expression Index.)
SecondaryAttention-Related Cognitive Errors Scale (ARCES) (Change)

Measure of everyday performance failures arising from brief failures of sustained attention. Min: 12, Max: 60 (lower scores are better)

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Attention-Related Cognitive Errors Scale (ARCES) (Change)
score on a scaleSTEP-HomePCGT
Baseline41.9 ± 12.442.7 ± 9.9
Post-Treatment38.2 ± 12.739.6 ± 12.9
Follow-Up37.7 ± 14.139.0 ± 11.7
SecondaryProblem Solving Inventory (PSI) (Change)

Measure of problem solving confidence, approach-avoidance style, and personal control. Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Total score calculated by adding the scores of all items. Problem-Solving Confidence: Min: 11, Max: 66 Approach-Avoidance Style: Min: 16, Max: 96 Personal Control: Min: 5, Max: 30 TOTAL score: Min: 32, Max: 192

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Problem Solving Inventory (PSI) (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score100.6 ± 21.9102.6 ± 21.7
Post-Treatment Total Score93.1 ± 22.094.1 ± 26.7
Follow-Up Total Score94.3 ± 24.095.3 ± 24.2
Baseline Problem Solving31.7 ± 8.531.5 ± 9.1
Post-Treatment Problem Solving27.3 ± 9.031.5 ± 9.1
Follow-Up Problem Solving28.2 ± 10.628.8 ± 9.6
Baseline Approach Avoidance49.4 ± 13.451.8 ± 13.3
Post-Treatment Approach Avoidance47.4 ± 11.247.6 ± 15.5
Follow-Up Approach Avoidance47.2 ± 11.747.6 ± 14.2
Baseline Personal Control20.3 ± 5.621.2 ± 4.8
Post-Treatment Personal Control18.4 ± 4.818.6 ± 5.6
Follow-Up Personal Control19.0 ± 5.019.0 ± 4.4
SecondaryDifficulties in Emotion Regulation Scale (DERS) (Change)

Measure to assess multiple aspects of emotion dysregulation. Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Nonacceptance of emotional responses: Min: 6, Max: 30 Difficulty engaging in goal-directed behavior: Min: 6, Max: 25 Impulse control difficulties: Min: 6, Max: 30 Lack of emotional awareness: Min: 6, Max: 30 Limited access to emotion regulation strategies: Min: 8, Max: 40 Lack of emotional clarity: Min: 5, Max: 25 TOTAL score: Min: 36, Max: 180, Total score calculated by adding the scores of all items (reverse scoring awareness items).

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Difficulties in Emotion Regulation Scale (DERS) (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score104.2 ± 26.0106.9 ± 24.3
Post-Treatment Total Score90.8 ± 26.197.6 ± 25.8
Follow-Up Total Score89.2 ± 30.094.0 ± 26.4
Baseline Non-Acceptance16.1 ± 7.418.0 ± 6.5
Post-Treatment Non-Acceptance15.0 ± 6.616.2 ± 5.9
Follow-Up Non-Acceptance14.7 ± 7.416.1 ± 7.4
Baseline Goals17.4 ± 4.917.7 ± 5.4
Post-Treatment Goals15.5 ± 5.616.6 ± 5.6
Follow-Up Goals14.7 ± 6.115.9 ± 5.2
Baseline Impulse15.3 ± 5.115.0 ± 6.3
Post-Treatment Impulse13.1 ± 4.413.5 ± 5.7
Follow-Up Impulse12.2 ± 5.012.5 ± 4.8
Baseline Awareness17.2 ± 5.619.0 ± 4.9
Post-Treatment Awareness16.2 ± 5.817.8 ± 5.7
Follow-Up Awareness16.5 ± 6.517.4 ± 5.6
Baseline Strategies23.3 ± 8.422.6 ± 7.4
Post-Treatment Strategies19.0 ± 8.020.2 ± 7.4
Follow-Up Strategies19.0 ± 8.519.5 ± 7.4
Baseline Clarity13.7 ± 4.714.8 ± 3.5
Post-Treatment Clarity12.0 ± 5.113.4 ± 4.0
Follow-Up Clarity12.1 ± 4.713.0 ± 4.3
SecondaryPTSD Checklist for DSM-5 (PCL-5) (Change)

A 20-item measure of PTSD updated for DSM-5. Min: 0, Max: 80 (lower scores are better)

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
PTSD Checklist for DSM-5 (PCL-5) (Change)
score on a scaleSTEP-HomePCGT
Baseline43.5 ± 20.144.9 ± 17.7
Post-Intervention36.3 ± 20.739.6 ± 19.4
Follow-Up34.9 ± 21.641.0 ± 20.6
SecondaryDepression Anxiety and Stress Scale (DASS-21) (Change)

A 21-item measure of current depression, anxiety, and stress. Each subscale Min: 7, Max: 28 (lower scores are better)

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Depression Anxiety and Stress Scale (DASS-21) (Change)
score on a scaleSTEP-HomePCGT
Baseline Anxiety15.4 ± 11.614.6 ± 10.0
Baseline Depression18.7 ± 12.319.0 ± 10.5
Baseline Stress20.7 ± 10.920.9 ± 9.0
Post-Intervention Anxiety12.7 ± 11.212.8 ± 9.6
Post-Intervention Depression16.0 ± 13.115.7 ± 10.6
Post-Intervention Stress17.1 ± 11.618.9 ± 9.4
Follow-Up Anxiety11.1 ± 10.612.8 ± 10.2
Follow-Up Depression12.7 ± 11.416.3 ± 10.0
Follow-Up Stress15.6 ± 10.418.8 ± 8.8
SecondaryNeurobehavioral Symptoms Inventory (NSI) (Change)

A 22-item measure of current post-concussive symptoms. Total score Min: 0, Max: 88 (lower scores are better), calculated by adding the scores of all of the subscales. Vestibular Min: 0, Max: 12 (3 items) Somatosensory Min: 0, Max: 20 (5 items) Affective Min: 0, Max: 24 (6 items) Cognitive Min: 0, Max: 32 (8 items)

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Neurobehavioral Symptoms Inventory (NSI) (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score39.2 ± 19.739.0 ± 16.7
Post-Intervention Total Score30.5 ± 19.535.0 ± 17.9
Follow-Up Total Score27.9 ± 19.136.3 ± 17.4
Baseline Vestibular3.3 ± 3.23.3 ± 2.9
Post-Treatment Vestibular2.5 ± 2.63.3 ± 2.8
Follow-Up Vestibular2.7 ± 2.94.2 ± 3.2
Baseline Somatic8.1 ± 6.69.0 ± 5.5
Post-Treatment Somatic6.6 ± 6.18.4 ± 5.6
Follow-Up Somatic7.0 ± 6.39.2 ± 5.7
Baseline Cognitive9.0 ± 4.09.4 ± 4.2
Post-Treatment Cognitive7.6 ± 4.98.0 ± 4.8
Follow-Up Cognitive6.6 ± 4.27.7 ± 4.2
Baseline Affective14.2 ± 6.313.4 ± 5.3
Post-Treatment Affective11.5 ± 6.812.3 ± 5.6
Follow-Up Affective9.4 ± 6.112.2 ± 5.7
SecondaryWorld Health Organization Disability Assessment Schedule-2.0 (WHODAS-2.0) (Change)

Measures functional states in six domains (understanding and communicating, getting around, self care, getting along with people, life activities (work/school), and participation in society). Possible raw min and max scores are below. For all subscales and total score, data is presented as a computed score in a range from 0-100. This is calculated by taking the raw score for each subscale and total score, dividing it by number of possible points for the relevant questions, and multiplying it by 100. Lower scores are better. Understanding and Communicating: Min: 0, Max: 24 Getting Around: Min: 0, Max: 20 Self Care: Min: 0, Max: 16 Getting Along with People: Min: 0, Max: 20 Life Activities: Min: 0, Max: 16 Work-School: Min: 0, Max: 16 Participation: Min: 0, Max: 32 Total Aggregate: Min: 0, Max: 144

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
World Health Organization Disability Assessment Schedule-2.0 (WHODAS-2.0) (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score39.2 ± 20.738.3 ± 18.1
Post-Treatment Total Score31.6 ± 22.733.5 ± 18.0
Follow-Up Total Score31.0 ± 21.633.7 ± 19.0
Baseline Communicating38.4 ± 22.041.1 ± 19.0
Post-Treatment Communicating35.3 ± 24.636.5 ± 21.6
Follow-Up Communicating31.3 ± 22.836.0 ± 20.6
Baseline Getting Around27.6 ± 26.824.8 ± 24.9
Post-Treatment Getting Around24.8 ± 24.926.4 ± 23.1
Follow-Up Getting Around24.9 ± 25.127.8 ± 25.0
Baseline Self-Care18.1 ± 22.718.4 ± 19.9
Post-Treatment Self-Care14.6 ± 21.013.9 ± 17.7
Follow-Up Self-Care13.8 ± 17.614.7 ± 18.9
Baseline Getting Along42.8 ± 25.546.7 ± 21.7
Post-Treatment Getting Along36.9 ± 27.840.4 ± 19.9
Follow-Up Getting Along34.4 ± 27.341.0 ± 22.6
Baseline Work/Activity39.8 ± 26.244.2 ± 24.4
Post-Treatment Work/Activity34.9 ± 28.639.7 ± 27.8
Follow-Up Work/Activity34.2 ± 26.437.2 ± 26.8
Baseline Participation41.4 ± 26.742.4 ± 19.8
Post-Treatment Participation35.9 ± 26.636.4 ± 21.3
Follow-Up Participation38.3 ± 27.338.0 ± 21.0
SecondarySatisfaction With Life Scale (SWLS) (Change)

A 5-item measure of satisfaction with life. Min: 5, Max: 35 (higher scores are better)

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Satisfaction With Life Scale (SWLS) (Change)
score on a scaleSTEP-HomePCGT
Baseline15.1 ± 7.115.3 ± 7.5
Post-Treatment18.0 ± 7.616.6 ± 7.7
Follow-Up17.8 ± 8.917.7 ± 7.8
SecondaryNumber of Participants Differing in Activity Engagement Over Time (Change)

Assesses engagement in school, work, and life activities. Participants self reported engagement in each category at each time point. Categories are not mutually exclusive, but rather indicate how many participants endorsed participating in each category at each time point. A scale is not used in this measure.

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Count of participants · Participants
Number of Participants Differing in Activity Engagement Over Time (Change)
ParticipantsSTEP-HomePCGT
Baseline Work4237
Baseline School/Training Programs1826
Baseline Volunteer Activities1519
Baseline Veteran-Oriented Programs2917
Baseline Community Activities1712
Baseline Socializing5046
Post-Intervention Work2220
Post-Intervention School/Training Programs1419
Post-Intervention Volunteer Activities1714
Post-Intervention Veteran-Oriented Programs2720
Post-Intervention Community Activities1213
Post-Intervention Socializing3437
Follow-Up Work1822
Follow-Up School/Training Programs816
Follow-Up Volunteer Activities1111
Follow-Up Veteran-Oriented Programs1511
Follow-Up Community Activities148
Follow-Up Socializing2625
SecondaryBarriers to Employment Success Inventory (BESI) (Change)

A measure of obstacles to employment in five areas (Personal/Financial, Emotional/Physical, Career Decision-Making and Planning, Job-Seeking Knowledge, and Training/Education). Min and max scores for all the subscales, and the total score, are below. For all, lower scores are better. Only total score analyzed, subscales not reported. Personal and Financial: Min: 10, Max: 40 Emotional and Physical: Min: 10, Max: 40 Career Decision-Making and Planning: Min: 10, Max: 40 Job-Seeking Knowledge: Min: 10, Max: 40 Training and Education: Min: 10, Max: 40 TOTAL score: Min: 50, Max: 200

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Barriers to Employment Success Inventory (BESI) (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score103.5 ± 33.9101.8 ± 32.9
Post-Treatment Total Score90.7 ± 33.996.3 ± 32.1
Follow-Up Total Score89.0 ± 35.988.3 ± 32.6
SecondaryNumber of Participants Differing in Average Number of Hours Worked (Change)

Change in average number of hours worked per month over time. Participants self-reported average number of hours worked in the month before STEP-Home (baseline), in each month of the intervention/PCGT (measured at post-treatment), and post-treatment monitoring (follow-up). A scale is not used in this measure. Each row indicates the number of participants that worked the indicated number of hours at each time point. Rows are mutually exclusive.

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Count of participants · Participants
Number of Participants Differing in Average Number of Hours Worked (Change)
ParticipantsSTEP-HomePCGT
Baseline <1 hour5355
Baseline 1-10 hours/week44
Baseline 11-20 hours/week36
Baseline 21-30 hours/week53
Baseline 31-40 hours/week910
Baseline >40 hours/week2010
Post-Intervention <1 hour/week3337
Post-Intervention 1-10 hours/week03
Post-Intervention 11-20 hours/week04
Post-Intervention 21-30 hours/week22
Post-Intervention 31-40 hours/week56
Post-Intervention >40 hours/week155
Follow-Up <1 hour/week2623
Follow-Up 1-10 hours/week22
Follow-Up 11-20 hours/week25
Follow-Up 21-30 hours/week02
Follow-Up 31-40 hours/week58
Follow-Up >40 hours/week95
SecondaryFrontal Systems Behavior Scale (FrSBe) (Change)

Measures apathy, disinhibition, and executive dysfunction. Min and max possible scores for subscales and total score are below. For all, lower scores are better. Total score calculated by adding the scores of all items. Subscale scores calculated by adding the scores of the items in each subscale. Apathy Min: 14, Max: 70 Disinhibition Min: 15, Max: 75 Executive Dysfunction Min: 17, Max: 85 Total Score Min: 46, Max: 230

Time frame:
Baseline, Post 12-Week Treatment, Post Treatment (24 week follow-up)
Reported as:
Mean · score on a scale
Frontal Systems Behavior Scale (FrSBe) (Change)
score on a scaleSTEP-HomePCGT
Baseline Total Score124.8 ± 25.9124.9 ± 25.8
Post-Treatment Total Score111.8 ± 25.6111.9 ± 25.0
Follow-Up Total Score109.2 ± 23.7110.2 ± 26.1
Baseline Apathy41.1 ± 9.843.2 ± 9.4
Post-Treatment Apathy36.2 ± 9.838.3 ± 10.2
Follow-Up Apathy35.8 ± 8.841.8 ± 9.3
Baseline Disinhibition37.6 ± 10.437.0 ± 8.4
Post-Treatment Disinhibition33.2 ± 9.631.8 ± 9.6
Follow-Up Disinhibition32.3 ± 9.631.1 ± 10.3
Baseline Executive Dysfunction45.6 ± 9.046.5 ± 8.1
Post-Treatment Executive Dysfunction42.4 ± 8.741.8 ± 9.3
Follow-Up Executive Dysfunction41.1 ± 7.841.8 ± 9.3

Adverse events

Collected over Baseline, post-intervention (12 weeks), follow-up (24 weeks). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
STEP-Home0/100 (0%)0/100 (0%)0/100 (0%)
PCGT0/95 (0%)0/95 (0%)0/95 (0%)

Baseline characteristics

Only participants with available baseline data are included in baseline demographic analyses

Age, Continuous
Age, Continuous(Years)STEP-HomePCGTTotal
Mean38.2 ± 10.339.8 ± 10.539.1 ± 10.4
Sex: Female, Male
Sex: Female, Male(Participants)STEP-HomePCGTTotal
Female252045
Male6871139
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)STEP-HomePCGTTotal
White6260122
Black192140
Asian213
American Indian/Alaskan Native448
Other15722
Hispanic232245
Branch of Service
Branch of Service(Participants)STEP-HomePCGTTotal
Army554398
Navy101222
Air Force5914
Marines111021
Coast Guard303
Missing Data6915
Multiple Branches3811
08

Study locations

2 sites
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts 02130-4817, United States
  • Michael E. DeBakey VA Medical Center, Houston, TX
    Houston, Texas 77030, United States
09

References and documents

Publications

  • Fortier CB, Currao A, Kenna A, Kim S, Beck BM, Katz D, Hursh C, Fonda JR. Online Telehealth Delivery of Group Mental Health Treatment Is Safe, Feasible, and Increases Enrollment and Attendance in Post-9/11 U.S. Veterans. Behav Ther. 2022 May;53(3):469-480. doi: 10.1016/j.beth.2021.11.004. Epub 2021 Nov 25. PubMed 35473650 ↗
  • Fortier CB, Kenna A, Katz D, Kim S, Hursh C, Beck B, Sablone CA, Currao A, Lebas A, Jorge RE, Fonda JR. STEP-Home transdiagnostic group reintegration workshop to improve mental health outcomes for post-9/11 Veterans: Design, methods, and rationale for a randomized controlled behavioral trial. Contemp Clin Trials. 2024 Jun;141:107536. doi: 10.1016/j.cct.2024.107536. Epub 2024 Apr 16. PubMed 38614448 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 1, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03868930
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Mar 11, 2019
Start date
Jun 17, 2019
Primary completion
Mar 29, 2024
Completion
Mar 29, 2024
Results posted
May 30, 2025
Last update
Oct 30, 2025

Study contacts

Catherine B Fortier, PhD
principal investigator · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion